2021
Therapy-induced senescence: opportunities to improve anticancer therapy.
Prasanna, P.G., Citrin, D.E., Hildesheim, J., Ahmed, M.M., Venkatachalam, S., Riscuta, G., Xi, D., Zheng, G., van Deursen, J., Goronzy, J., Kron, S.J., Anscher, M.S., Sharpless, N.E., Campisi, J., Brown, S.L., Niedernhofer, L.J., O'Loghlen, A., Georgakilas, A.G., Paris, F., Gius, D., Gewirtz, D.A., Schmitt, C.A., Abazeed, M.E., Kirkland, J.L., Richmond, A., Romesser, P.B., Lowe, S.W., Gil, J., Mendonca, M.S., Burma, S., Zhou, D. and Coleman, C.N.
Journal of the National Cancer Institute 113
(10): 1285-1298.
October 2021
2015
A prospective study of the immune system activation biomarker neopterin and colorectal cancer risk.
Aleksandrova, K., Chuang, S.C., Boeing, H., Zuo, H., Tell, G.S., Pischon, T., Jenab, M., Bueno-de-Mesquita, B., Vollset, S.E., Midttun, Ø., Ueland, P.M., Fedirko, V., Johansson, M., Weiderpass, E., Severi, G., Racine, A., Boutron-Ruault, M.C., Kaaks, R., Kühn, T., Tjønneland, A., Overvad, K., Quirós, J.R., Jakszyn, P., Sánchez, M.J., Dorronsoro, M., Chirlaque, M.D., Ardanaz, E., Khaw, K.T., Wareham, N.J., Travis, R.C., Trichopoulou, A., Lagiou, P., Trichopoulos, D., Palli, D., Sieri, S., Tumino, R., Panico, S., May, A.M., Palmqvist, R., Ljuslinder, I., Kong, S.Y.J., Freisling, H., Gunter, M.J., Lu, Y., Cross, A.J., Riboli, E. and Vineis, P.
Journal of the National Cancer Institute 107
(4): djv010.
April 2015
2014
Plasma alkylresorcinols, biomarkers of whole-grain wheat and rye intake, and incidence of colorectal cancer.
Kyrø, C, Olsen, A, Landberg, R, Skeie, G, Loft, S, Åman, P, Leenders, M, Dik, VK, Siersema, PD, Pischon, T., Christensen, J, Overvad, K, Boutron-Ruault, MC, Fagherazzi, G, Cottet, V, Kühn, T, Chang-Claude, J, Boeing, H, Trichopoulou, A, Bamia, C, Trichopoulos, D, Palli, D, Krogh, V, Tumino, R, Vineis, P, Panico, S, Peeters, PH, Weiderpass, E, Bakken, T, Åsli, LA, Argüelles, M, Jakszyn, P, Sánchez, MJ, Amiano, P, Huerta, JM, Barricarte, A, Ljuslinder, I, Palmqvist, R, Khaw, KT, Wareham, N, Key, TJ, Travis, RC, Ferrari, P, Freisling, H, Jenab, M, Gunter, MJ, Murphy, N, Riboli, E, Tjønneland, A and Bueno-de-Mesquita, HB
Journal of the National Cancer Institute 106
(1): djt352.
1 January 2014
2011
Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study.
Trichopoulos, D., Bamia, C., Lagiou, P., Fedirko, V., Trepo, E., Jenab, M., Pischon, T., Noethlings, U., Overved, K., Tjonneland, A., Outzen, M., Clavel-Chapelon, F., Kaaks, R., Lukanova, A., Boeing, H., Aleksandrova, K., Benetou, V., Zylis, D., Palli, D., Pala, V., Panico, S., Tumino, R., Sacerdote, C., Bueno-De-Mesquita, H.B., Van Kranen, H.J., Peeters, P.H., Lund, E., Quiros, J.R., Gonzalez, C.A., Sanchez Perez, M.J., Navarro, C., Dorronsoro, M., Barricarte, A., Lindkvist, B., Regner, S., Werner, M., Hallmans, G., Khaw, K.T., Wareham, N., Key, T., Romieu, I., Chuang, S.C., Murphy, N., Boffetta, P., Trichopoulou, A. and Riboli, E.
Journal of the National Cancer Institute 103
(22): 1686-1695.
16 November 2011
Severe peripheral arterial disease during nilotinib therapy.
Le Coutre, P., Rea, D., Abruzzese, E., Dombret, H., Trawinska, M.M., Herndlhofer, S., Doerken, B. and Valent, P.
Journal of the National Cancer Institute 103
(17): 1347-1348.
7 September 2011
Novel effect of antihelminthic niclosamide on S100A4-mediated metastatic progression in colon cancer.
Sack, U., Walther, W., Scudiero, D., Selby, M., Kobelt, D., Lemm, M., Fichtner, I., Schlag, P.M., Shoemaker, R.H. and Stein, U.
Journal of the National Cancer Institute 103
(13): 1018-1036.
6 July 2011
2010
Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.
Penack, O., Henke, E., Suh, D., King, C.G., Smith, O.M., Na, I.K., Holland, A.M., Ghosh, A., Lu, S.X., Jenq, R.R., Liu, C., Murphy, G.F., Lu, T.T., May, C., Scheinberg, D.A., Gao, D.C., Mittal, V., Heller, G., Benezra, R. and van den Brink, M.R.M.
Journal of the National Cancer Institute 102
(12): 894-908.
16 June 2010
2006
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).
Pischon, T., Lahmann, P.H., Boeing, H., Friedenreich, C., Norat, T., Tjonneland, A., Halkjaer, J., Overvad, K., Clavel-Chapelon, F., Boutron-Ruault, M.C., Guernec, G., Bergmann, M.M., Linseisen, J., Becker, N., Trichopoulou, A., Trichopoulos, D., Sieri, S., Palli, D., Tumino, R., Vineis, P., Panico, S., Peeters, P.H., Bueno-de-Mesquita, H.B., Boshuizen, H.C., Van Guelpen, B., Palmqvist, R., Berglund, G., Gonzalez, C.A., Dorronsoro, M., Barricarte, A., Navarro, C., Martinez, C., Quiros, J.R., Roddam, A., Allen, N., Bingham, S., Khaw, K.T., Ferrari, P., Kaaks, R., Slimani, N. and Riboli, E.
Journal of the National Cancer Institute 98
(13): 920-931.
5 July 2006
2004
A molecular genetic and statistical approach for the diagnosis of dual-site cancers.
Brinkmann, D., Ryan, A., Ayhan, A., McCluggage, W.G., Feakins, R., Santibanez-Koref, M.F., Mein, C.A., Gayther, S.A. and Jacobs, I.J.
Journal of the National Cancer Institute 96
(19): 1441-1446.
1 January 2004
2002
Cancer Incidence in BRCA1 mutation carriers.
Thompson, D., Easton, D.F., Scherneck, S. and Seitz, S.
Journal of the National Cancer Institute 94
(18): 1358-1365.
18 September 2002
1998
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.
Lakhani, S.R., Jacquemier, J., Sloane, J.P., Gusterson, B.A., Anderson, T.J., Vandevijver, M.J., Farid, L.M., Venter, D., Antoniou, A., Storferisser, A., Smyth, E., Steel, C.M., Haites, N., Scott, R.J., Goldgar, D., Neuhausen, S., Daly, P.A., Ormiston, W., Mcmanus, R., Scherneck, S., Ponder, B.A.J., Ford, D., Peto, J., Stoppa-Lyonnet, D., Bignon, Y.J., Struewing, J.P., Spurr, N.K., Bishop, D.T., Klijn, J.G.M., Devilee, P., Cornelisse, C.J., Lasset, C., Lenoir, G., Barkardottir, R.B., Egilsson, V., Hamann, U., Changclaude, J., Sobol, H., Weber, B., Stratton, M.R. and Easton, D.F.
Journal of the National Cancer Institute 90
(15): 1138-1145.
5 August 1998
1997
Tumor necrosis factor-alpha and expression of the multidrug resistance-associated genes LRP and MRP.
Stein, U., Walther, W., Laurencot, C.M., Scheffer, G.L., Scheper, R.J. and Shoemaker, R.H.
Journal of the National Cancer Institute 89
: 807-813.
1 January 1997
1996
Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells.
Stein, U., Walther, W. and Shoemaker, R.H.
Journal of the National Cancer Institute 88
: 1383-1392.
1 January 1996
This list was generated on Mon Nov 11 17:15:33 2024 UTC.